Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided TPVB plus Hydromorphone vs Sufentanil PCIA after Thoracoscopic Surgery
ChiCTR2600124063Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydromorphone in postoperative pain (4 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoint: VAS pain scores at rest and during activity at 24 hours postoperatively. Started May 2026; status: recruiting.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600124063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124063.